Related references
Note: Only part of the references are listed.Complex target SELEX
Steven M. Shamah et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Cell-specific internalization study of an aptamer from whole cell selection
Zeyu Xiao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Cell-specific aptamer probes for membrane protein elucidation in cancer cells
Dihua Shangguan et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Frank Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Polymer-caged lipsomes: A pH-Responsive delivery system with high stability
Sang-Min Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Targeted drug delivery utilizing protein-like molecular architecture
Evonne M. Rezler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Synthesis of a liposome incorporated 1-carboxyalkylxanthine-phospholipid conjugate and its recognition by an RNA aptamer
Katie A. Edwards et al.
TALANTA (2007)
Aptamers evolved from live cells as effective molecular probes for cancer study
Dihua Shangguan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
OC Farokhzad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pros and cons of the liposome platform in cancer drug targeting
Alberto A. Gabizon et al.
JOURNAL OF LIPOSOME RESEARCH (2006)
General method for modification of liposomes for encoded assembly on supported bilayers
C Yoshina-Ishii et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
On the formulation of pH-sensitive long circulation times
S Simoes et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody
AN Lukyanov et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma
U Wollina et al.
CANCER (2003)
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer:: in vivo studies
S Dagar et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: Evaluation in vitro and in vivo
CP Leamon et al.
BIOCONJUGATE CHEMISTRY (2003)
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels
D Hallahan et al.
CANCER CELL (2003)
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins
E Mastrobattista et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels
T Asai et al.
FEBS LETTERS (2002)
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors
YJ Lu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
M Schmidinger et al.
BRITISH JOURNAL OF CANCER (2001)
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)